Dosage and usage of viloxazine hydrochloride

Viloxazine Hydrochloride, sold under the trade name Qelbree, is primarily used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents. Based on clinical studies and FDA-approved guidelines, the dosage of veloxazine varies based on the patient's age and individual response. When patients start using this drug, they usually gradually adjust the dose according to their doctor's recommendations to achieve optimal therapeutic effects and reduce side effects.

For pediatric and adolescent patients 6 years of age and older, veloxazine is usually initiated at an initial dose of 100 mg once daily. To minimize adverse effects, treatment is usually started at a lower dose, and the dose can be adjusted as needed as the patient gradually increases his or her tolerance of the drug. Doctors usually monitor patients for treatment response and side effects over several weeks, increasing the dose if necessary.

The dose of veloxazine is usually titrated based on patient tolerance and response to treatment. For children 6 to 11 years old, the maximum recommended dose of veloxazine is 200< per day /span>mg; for adolescents 12 years and older, the maximum dose is 400mg per day. Generally speaking, the dose of the drug should be adjusted in stages, with an interval of about 1 to 2 weeks until the maximum dose or best effect is reached. Doctors should guide you when increasing the dose to prevent patients from adjusting the dose on their own.

Veloxazine should be taken orally once daily, preferably at the same time, to ensure stability of efficacy. The drug can be taken with food at any time and is usually not affected by food. Patients can choose to take it before or after meals according to personal habits. For children and adolescents, they should maintain an appropriate amount of water when taking medication to help absorb the medication and reduce possible gastrointestinal discomfort. Patients should not change the medication time or dosage without doctor's approval to avoid affecting the therapeutic effect.

When using veloxazine, patients should regularly evaluate the drug's efficacy and side effects according to their doctor's guidance. During the treatment process, patients may experience some side effects, such as drowsiness, loss of appetite, etc. If these side effects affect daily life or treatment effects, the doctor may adjust the dosage according to the situation. In addition, in patients with hepatic and renal dysfunction, the dose of veloxazine may need to be adjusted based on their specific conditions. Any dosage adjustments should be made under the guidance of a professional physician to ensure the safety and effectiveness of treatment.

Reference materials:https://www.qelbree.com/